Ehud Schwammenthal, MD, PhD Associate Professor of Cardiology

Slides:



Advertisements
Similar presentations
Thirty-day Outcomes from the Multi-centre European Pivotal Trial for Transapical Transcatheter Aortic Valve Implantation with a Self-expanding Prosthesis.
Advertisements

INTERNATIONAL CAUTION: For distribution only in markets where Engager has been approved. Not approved in the USA, Canada, or Japan. Medtronic Engager Transcatheter.
Medtronic Engager™ Transcatheter Aortic Valve Implantation System Procedure Quick Review And Tips August 2013 Innovating for life. UC a EE Engager.
ATS 3f® Aortic Bioprosthesis
ACC 2015 Jae K. Oh, MD On Behalf of the US CoreValve Investigators Remodeling of Self-Expanding Transcatheter Aortic Valve Is Responsible for Regression.
ACC 2015 Michael J Reardon, MD, FACC On Behalf of the CoreValve US Investigators A Randomized Comparison of Self-expanding Transcatheter and Surgical Aortic.
Long-Term Outcomes Using a Self- Expanding Bioprosthesis in Patients With Severe Aortic Stenosis Deemed Extreme Risk for Surgery: Two-Year Results From.
INTERNATIONAL. CAUTION: For distribution only in markets where CoreValve® is approved. Not for distribution in U.S., Canada or Japan. Medtronic, Inc
University Heart Center Hamburg
CoreValve® System Procedural Best Practices for:
Impact of Concomitant Tricuspid Annuloplasty on Tricuspid Regurgitation Right Ventricular Function and Pulmonary Artery Hypertension After Degenerative.
Trans-catheter Aortic Valve Replacement: a UK update. Dr Martyn Thomas Guys and St Thomas’ Hospital.
A shifting paradigm of care: Advances in transcatheter heart valve procedures Sandra Lauck MSN, RN, CCN(C) Clinical Nurse Specialist, Arrhythmia Management.
Prosthesis-Patient Mismatch in High Risk Patients with Severe Aortic Stenosis in a Randomized Trial of a Self-Expanding Prosthesis George L. Zorn, III.
Axel Linke University of Leipzig Heart Center, Leipzig, Germany Sabine Bleiziffer German Heart Center, Munich, Germany Johan Bosmans University Hospital.
Tri-leaflet Aortic Valve. Aortic Stenosis Nishimura, RA et al AHA/ACC Valvular Heart Disease Guideline.
UC c EN. Through Medtronic sponsored research, the Transcatheter Aortic Valves clinical portfolio is studying over 11,000 subjects at over 125.
Transcatheter Cardiovascular Therapeutics 2008 (October 12-17, 2008 · Washington, DC) First-in-Human Report: Initial Experience with a Stentless and Retrievable.
Twelve Months and Beyond: Long-Term Results of the Direct Flow Medical Repositionable and Retrievable Pericardial Valve for Percutaneous Aortic Valve Replacement.
Longest Follow-up After Implantation of a Self-Expanding Repositionable Transcatheter Aortic Valve: Final Follow-up of the Evolut R CE Study Stephen Brecker,
VSD post TAVR: Mechanisms, Presentation and Management
TAVR for the Treatment of Pure Native Aortic Valve Regurgitation
Percutaneous valve devices
Transcatheter Mitral Valve Replacement
The Medtronic Ventor EngagerTM TAVI System
Transcatheter Aortic Valve Replacement Using the Lotus Valve with Depth Guard First Report from the RESPOND Extension Study Nicolas M Van Mieghem, MD,
Initial center experience with the St
Direct Flow Medical Experience with a Conformable, Repositionable, Retrievable, Percutaneous Aortic Valve Reginald Low MD University of California,Davis.
Optimizing Valve Sizing: Role of CT vs. Echo
Updates From NOTION: The First All-Comer TAVR Trial
Valve Durability Considerations: Fluid Dynamic Principles, Assessment Techniques, Predictors, and Minimum Standards Jorge H. Jimenez, Ph.D. Georgia Institute.
EVOLUT R, Next Generation, and Future
Hans R. Figulla MD,PhD University Heart Center, Jena, Germany
Review of the Latest OUS Data from the Self-Expanding Valve Studies
First Report of One-Year Outcomes of the REPRISE I Feasibility Study of the Repositionable Lotus Aortic Valve Replacement System Ian T. Meredith.
30-Day Safety and Echocardiographic Outcomes Following Transcatheter Aortic Valve Replacement with the Self-Expanding Repositionable Evolut PRO System.
Endurant: A New Generation Endograft
First Report of Three-Year Outcomes With the Repositionable and Fully Retrievable Lotus™ Aortic Valve Replacement System: Results From the REPRISE I.
Early Outcomes with the Evolut R Repositionable Self-Expanding Transcatheter Aortic Valve in the United States Mathew Williams, MD, For the Evolut R US.
Optimizing Valve Sizing: Role of CT vs. Echo
5th Meeting on Acute Cardiac Care and Emergency Medicine, 2016 Vilnius
Giuseppe Tarantini MD, PhD
Direct Flow Medical Experience with a Conformable, Repositionable Retrievable Percutaneous Aortic Valve Reginald Low MD University of California, Davis.
TAVI „Catch me if you can!“
Keith Dawkins MD FRCP FACC FSCAI Global Chief Medical Officer
Two-Year Outcomes With the Fully Repositionable and Retrievable Lotus™ Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients With Severe.
Opportunities to Study Valve Iterations and Modifications in the US
Longevity of transcatheter and surgical bioprosthetic aortic valves in patients with severe aortic stenosis and lower surgical risk Lars Sondergaard,
CRT 2010 Washington DC, January 21, 2010
Progress with the Sadra Medical Lotus™ Valve System
CRT 2010 Washington DC, January 21, 2010
One Year Outcomes in Real World Patients Treated with Transcatheter Aortic Valve Implantation The ADVANCE Study Axel Linke University of Leipzig Heart.
Second Generation Valves: What Will Be Different?
University Heart Center Hamburg
Ischemic Mitral Regurgitation: Chordal-Sparing Mitral Valve Replacement  Tirone E. David, MD  Operative Techniques in Thoracic and Cardiovascular Surgery 
S.G. Worthley, MB, BS, PhD., S. Redwood, MD, PhD.,
Late Follow-Up from the PARTNER Aortic Valve-in-Valve Registry
Real-Time Magnetic Resonance–Guided Aortic Valve Replacement Using Engager Valve  Bogdan A. Kindzelski, BS, Ming Li, PhD, Dumitru Mazilu, PhD, Timothy.
Development of Off-Pump Mitral Valve Replacement in a Porcine Model
Edward H. Kincaid, MD, Neal D. Kon, MD 
Ischemic Mitral Regurgitation: Chordal-Sparing Mitral Valve Replacement  Tirone E. David, MD  Operative Techniques in Thoracic and Cardiovascular Surgery 
First North American Experience With the Engager Self-Expanding Transcatheter Aortic Valve: Insights From the London Health Sciences Centre Heart Team 
Transapical transcatheter aortic valve-in-valve implantation: Clinical and hemodynamic outcomes beyond 2 years  Jian Ye, MD, FRCSC, John G. Webb, MD,
Tubular heart valves: A new tissue prosthesis design—Preclinical evaluation of the 3F aortic bioprosthesis  James L. Cox, MD, Niv Ad, MD, Keith Myers,
Five-Year Outcomes after Randomization to Transcatheter or Surgical Aortic Valve Replacement: Final Results of The PARTNER 1 Trial Michael J. Mack, MD.
Transapical off-pump removal of the native aortic valve: A proof-of-concept animal study  Stefano Salizzoni, MD, Pietro Bajona, MD, Kenton J. Zehr, MD,
The St Jude Medical Trifecta aortic pericardial valve: Results from a global, multicenter, prospective clinical study  Joseph E. Bavaria, MD, Nimesh D.
Malrotated sinus vortices in straight graft valve-sparing aortic root treatment: A matter of concern?  Thekla H. Oechtering, MD, Alex Frydrychowicz, MD,
Transcarotid Artery Revascularization
Nat. Rev. Cardiol. doi: /nrcardio
Presentation transcript:

Self-expanding, anatomically correct transapical aortic valve implantation Ehud Schwammenthal, MD, PhD Associate Professor of Cardiology Sheba Medical Center, Tel Hashomer, Israel

Ehud Schwammenthal, MD, PhD DISCLOSURES Ehud Schwammenthal, MD, PhD Consulting Fees Medtronic CardioVascular, Inc. Honoraria The Engager device is not commercially available in any geography and only available for Clinical Study in the EU

Medtronic Engager Design Concept Self-expandable transcatheter valve Minimizes pressure loss at the inlet Maximizes pressure recovery at the outlet Optimized fluid dynamic shape (Venturi tube) allows to avoid oversizing of the diameter at annular-leaflet level Resulting shape – inlet, waist, outlet – creates an optimal anatomic fit facilitating intuitive deployment and axial fixation

Venturi Tube Principle Outlet geometry allowing gradual expansion of streamlines eliminates flow separation and prevents turbulence (pressure recovery) Abrupt outflow (nozzle): turbulence, head loss Gradually expanding outflow: eliminates flow separation and recovers the pressure drop Prandtl L, Tietjens O: Applied Hydro- and Aeromechanics, New York, Dover 1957

Valve Hemodynamics EOA: 1.62 cm2 (5L/min) Producing the hemodynamics of a 23 valve without oversizing at the native aortic orifice (CE Magna 21: 1.48 cm2 , Mitroflow 23: 1.57 cm2)* *Gerosa et al, The Journal of Thoracic and CV Surgery, May 2006

Medtronic Engager Transcatheter Valve Scalloped bovine pericardial leaflets Dedicated commissural posts Nitinol main frame Nitinol support frame The valve’s outlet section is designed as a regular surgical bioprosthesis dedicated commissural posts scalloped bovine pericardial lealfets not encompassed by a metal stent frame, so that they are folded rather than compressed during valve loading Polyester skirt 6

Medtronic Engager Implantation

Shape creates anatomical fit: positioning and fixation Medtronic Engager Shape creates anatomical fit: positioning and fixation Shape facilitates implementation of a periannular anchoring system for intuitive and accurate deployment, anatomical positioning and axial fixation The native leaflets are embraced between an inlet and a 3D support frame tracking the shape of the aortic root Arms at the floor of the sinuses, prosthetic commissural posts riding astride the native commissures Periannular fixation – anatomically correct supraannular position

Shape creates anatomical fit: positioning and fixation Medtronic Engager Shape creates anatomical fit: positioning and fixation Native leaflets are prevented from being pushed against coronary ostia. Native leaflets held against the mainframe and thus recruited to seal off potential perivalvular regurgitation. Native leaflets are kept below the prosthetic leaflets, allowing the prosthetic leaflets to interact with the natural vortex flow in the sinuses for optimal closing. α Design (shape) causes support arms to maintain a predesigned angle upon deployment

Medtronic Engager Leaflet Kinematics Leonardo da Vinci B C D A Gharib M, et al. Exp in Fluids 2003

Medtronic Engager Rotational Positioning RAO R N L 11 11

Medtronic Engager Rotational Positioning LAO R N L 12

CRL 1. Establish delivery axis as the commissure between 2 sinuses 2. Align window of prosthetic commissural post with native one LCS RCS CRL Delivery Axis Commissure is the tip of the intercusp triangle spared by contrast medium

Taped Case 3:20

Post-Implantation rotational angiography (Dyna CT)

FIM: Baseline Characteristics 30 patients, 25 female (83%) and 5 male Age: 83 ± 4 years Logistic EuroSCORE: 23±12.0 % Functional Class: 90% NYHA III and IV Pressure Gradient: Peak 86±22 mmHg (56.0-143.0) Mean 52±14 mmHg Concomitant AR: None - 17% I - 57%, II - 23%, III - 3%

FIM: Placement and Hemodynamics Accurate placement in 29/30 (97%) No device embolization Pressure gradient: Peak-to-peak 13 ± 9 mmHg Peak 24 ± 10 mmHg Mean 12 ± 6 mmHg Aortic regurgitation : None or trace 30% I 47% I-II 13% II 3%

FIM: Procedural Details Skin-to-skin time 74 ±16 minutes Implantation time: 5.9±2.4 minutes Contrast medium volume: 130±58 ml Fluoroscopy time: 7.5±2.6 minutes Mention only means Contrast medium 330ml first case PG invasively measured… and the corresponded mean pressure… AR – up to 1 - 60%, no grade 3 or 4

FIM: Procedure Outcome No coronary obstruction No stroke or myocardial infarction PM implantation for AV conduction blocks 3/30 Mortality at 30 days 20%, all non-device related (No perioperative mortality in the last 12 cases) Conversion to surgery for aortic dissection: 3/30

General Misconception “[Access to] the aortic valve from the left ventricular apex is straight and relatively short”, Dewey TM, Walther T, Mack MJ, et al Ann Thorac Surg 2006 and 2009 LAO

LAO view creates impression of relatively straight access. BUT, the ventriculo-aortic angle can be appropriately appreciated only in the RAO view. RAO equiv LAO equiv

Learned to use RAO to guide adjustment of delivery angle (correct misplacement of support arm below NCS if needed) Before After

Learned to use of RAO to monitor advancement of delivery catheter to avoid injury to aortic wall

Learnings from Feasibility Study: Need for Delivery System Improvements Flexible over-the-wire design (forgiving) Full coverage of commissural posts to protect aorta until device is positioned Mechanism for release of support arms that does not require advancing the delivery catheter further into aorta Converted delivery into one-piece system (no need for exchange of dilator) to streamline procedure

Summary – Medtronic Engager Self-guided, reproducible and intuitive deployment into an anatomically correct position Relies on axial in addition to radial forces for fixation Leaves the coronary ostia unobstructed and accessible Reduces the risk of perivalvular regurgitation Applies proven surgical design standards for long-term durability Enhancements of the delivery system are under way in preparation of EU Pivotal Trial (2010)

Thank You !